SEC Tracker
Get the app

INSMED INSM

John Drayton Wise (Officer) plans to sell 1,602 INSM shares, about $78,418

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: May 28, 2024
  2. Broker: Merrill Lynch
  3. Shares acquired by: Stock Plan Activity

All of John Drayton Wise's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 1,602 shares at $48.95 on May 28, 2024 ยท Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when INSMED files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  2. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  3. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  4. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  5. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025